What amount sold does Etheros Pharmaceuticals Corp. report in Form D filings?

The latest linked filings report $1.7M sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Etheros Pharmaceuticals Corp.'s most recent SEC filing?

Etheros Pharmaceuticals Corp.'s most recent Form D filing was on 2025-06-10.

How many investors does Etheros Pharmaceuticals Corp. have?

The most recent Form D filing lists 6 investor(s).

Etheros Pharmaceuticals Corp.

CIK: 0002005132·Pharmaceuticals·NASHVILLE, TN·Corporation·Founded 2022

Reported Sold

$1,675,000

Total Filings

Identified Offerings

Last Filed

Jun 10, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Jun 10, 2025Form D — New notice

Reported sold: $600,000 · Target: $600,000

Rule 506(b)·6 investors

Dec 20, 2023Form D — New notice

Reported sold: $775,000 · Target: $775,000

Rule 506(b)·5 investors

Dec 20, 2023Form D — New notice

Reported sold: $300,000 · Target: $300,000

Rule 506(b)·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 3 identified offerings

$1,675,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

John William Scannell

Related Person

Appears on 3 filings

Marc Feldmann

Related Person

Appears on 3 filings

Laura Dugan

Related Person

Appears on 3 filings

Francis Knuettel II

Related Person

Appears on 3 filings

Subhasish Chakraborty

Related Person

Appears on 3 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jun 10, 2025	New	$600,000	$600,000	6
Dec 20, 2023	New	$775,000	$775,000	5
Dec 20, 2023	New	$300,000	$300,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

EpiVario Inc.

Pharmaceuticals

Offering target: $500,000

Filed Oct 13, 2026